Altieri Richard M. 4
4 · Oxford Immunotec Global PLC · Filed Mar 19, 2018
Insider Transaction Report
Form 4
Altieri Richard M.
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2018-03-15+34,661→ 34,661 totalExercise: $13.24Exp: 2028-03-15→ Ordinary Shares (34,661 underlying) - Award
Ordinary Shares
2018-03-15+7,926→ 210,891 total
Footnotes (2)
- [F1]Options granted under Issuer's 2013 Share Incentive Plan.
- [F2]Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2019 through January 1, 2022.